Ann Berry

"I think where we've seen the baby being thrown out with the bath water is a little bit in the software selloff... I do think cybersecurity stocks remain oversold. I'm watching CrowdStrike get down this morning, and that's an opportunity." The broader market selloff driven by geopolitical fears and AI rotation has disproportionately hit high-quality software names. Companies with proprietary data and strong ROI for customers have pricing power and will rebound once macro fears subside. LONG. CrowdStrike represents an oversold, high-quality asset in a critical sector (cybersecurity) that is being unfairly punished by macro noise. Prolonged macro uncertainty or a broader recession could cause enterprise IT budgets to contract, impacting software growth rates.

Henry Schein is a $10B market cap healthcare distributor trading at ~11x EBITDA. Healthcare demand is rising and is not "AI-displaceable" (physical goods to vets/doctors). However, the business is "AI-Enhanceable" via better demand planning and SKU management, which can expand margins. LONG. A value play in an expensive market. Healthcare regulatory changes.

Palo Alto Networks has been punished recently (down ~22% over a year mentioned in context), but cybersecurity demand is non-discretionary. Unlike CRM, cybersecurity is "AI-Enhanceable" rather than "AI-Replaceable." AI creates *more* threats, increasing demand for PANW's services. The market is wrongly throwing the baby out with the bathwater by grouping it with vulnerable SaaS. LONG. Strong entry point for a mission-critical sector. Integration execution risks.

Clear Secure is expanding partnerships (e.g., Mount Sinai) beyond just airport security. In an AI world of deepfakes and data insecurity, trusted biometric identity verification becomes a high-value moat. Consumers trust YOU with biometric data, allowing them to expand into medical records and other verticals. LONG. Regulatory pushback on biometric data usage.